These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 18372651)

  • 1. Mode of action of fenarimol against Leishmania spp.
    Zeiman E; Greenblatt CL; Elgavish S; Khozin-Goldberg I; Golenser J
    J Parasitol; 2008 Feb; 94(1):280-6. PubMed ID: 18372651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel azasterols as potential agents for treatment of leishmaniasis and trypanosomiasis.
    Lorente SO; Rodrigues JC; Jiménez Jiménez C; Joyce-Menekse M; Rodrigues C; Croft SL; Yardley V; de Luca-Fradley K; Ruiz-Pérez LM; Urbina J; de Souza W; González Pacanowska D; Gilbert IH
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2937-50. PubMed ID: 15273104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biphenylquinuclidines as inhibitors of squalene synthase and growth of parasitic protozoa.
    Orenes Lorente S; Gómez R; Jiménez C; Cammerer S; Yardley V; de Luca-Fradley K; Croft SL; Ruiz Perez LM; Urbina J; Gonzalez Pacanowska D; Gilbert IH
    Bioorg Med Chem; 2005 May; 13(10):3519-29. PubMed ID: 15848765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of intracellular proliferation of Leishmania parasites in vitro and suppression of skin lesion development in BALB/c mice by a novel lipid A analog (ONO-4007).
    Khan MA; Maruno M; Khaskhely NM; Ramzi ST; Hosokawa A; Uezato H; Landires EA; Hashiguchi Y; Nonaka S
    Am J Trop Med Hyg; 2002 Aug; 67(2):184-90. PubMed ID: 12389945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing Glyburide as Antileishmanial Agent to Fight Against Leishmaniasis.
    Rub A; Shaker K; Kashif M; Arish M; Dukhyil AAB; Alshehri BM; Alaidarous MA; Banawas S; Amir K
    Protein Pept Lett; 2019; 26(5):371-376. PubMed ID: 30827222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and anti-leishmanial activity of novel symmetrical bispyridinium cyclophanes.
    Gómez-Pérez V; Manzano JI; García-Hernández R; Castanys S; Gamarro F; Campos JM
    Eur J Med Chem; 2015 Jan; 89():362-9. PubMed ID: 25462252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of azoles targeting sterol 14α-demethylase for antileishmanial therapy.
    Emami S; Tavangar P; Keighobadi M
    Eur J Med Chem; 2017 Jul; 135():241-259. PubMed ID: 28456033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of anti-cancer protein kinase inhibitors against Leishmania spp.
    Sanderson L; Yardley V; Croft SL
    J Antimicrob Chemother; 2014 Jul; 69(7):1888-91. PubMed ID: 24668412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel organic salts based on quinoline derivatives: The in vitro activity trigger apoptosis inhibiting autophagy in Leishmania spp.
    Calixto SL; Glanzmann N; Xavier Silveira MM; da Trindade Granato J; Gorza Scopel KK; Torres de Aguiar T; DaMatta RA; Macedo GC; da Silva AD; Coimbra ES
    Chem Biol Interact; 2018 Sep; 293():141-151. PubMed ID: 30098941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sterol profiling of Leishmania parasites using a new HPLC-tandem mass spectrometry-based method and antifungal azoles as chemical probes reveals a key intermediate sterol that supports a branched ergosterol biosynthetic pathway.
    Feng M; Jin Y; Yang S; Joachim AM; Ning Y; Mori-Quiroz LM; Fromm J; Perera C; Zhang K; Werbovetz KA; Wang MZ
    Int J Parasitol Drugs Drug Resist; 2022 Dec; 20():27-42. PubMed ID: 35994895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Ergosterol biosynthesis in Leishmania donovani: essentiality of sterol 14 alpha-demethylase.
    McCall LI; El Aroussi A; Choi JY; Vieira DF; De Muylder G; Johnston JB; Chen S; Kellar D; Siqueira-Neto JL; Roush WR; Podust LM; McKerrow JH
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003588. PubMed ID: 25768284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and in-vitro anti-leishmanial activity of (4-arylpiperazin-1-yl)(1-(thiophen-2-yl)-9H-pyrido[3,4-b]indol-3-yl)methanone derivatives.
    Ashok P; Chander S; Chow LM; Wong IL; Singh RP; Jha PN; Sankaranarayanan M
    Bioorg Chem; 2017 Feb; 70():100-106. PubMed ID: 27939960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular docking, structure-activity relationship and biological evaluation of the anticancer drug monastrol as a pteridine reductase inhibitor in a clinical isolate of Leishmania donovani.
    Kaur J; Sundar S; Singh N
    J Antimicrob Chemother; 2010 Aug; 65(8):1742-8. PubMed ID: 20519355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructural Investigation of
    Shokri A; Fakhar M; Emami S; Gill P; Akhtari J
    Recent Pat Antiinfect Drug Discov; 2018; 13(3):246-255. PubMed ID: 30227826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective leishmanicidal effect of 1,3,4-thiadiazole derivatives and possible mechanism of action against Leishmania species.
    Poorrajab F; Ardestani SK; Foroumadi A; Emami S; Kariminia A; Behrouzi-Fardmoghadam M; Shafiee A
    Exp Parasitol; 2009 Apr; 121(4):323-30. PubMed ID: 19124020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lathosterol Oxidase (Sterol C-5 Desaturase) Deletion Confers Resistance to Amphotericin B and Sensitivity to Acidic Stress in Leishmania major.
    Ning Y; Frankfater C; Hsu FF; Soares RP; Cardoso CA; Nogueira PM; Lander NM; Docampo R; Zhang K
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32611698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the antileishmanial mechanism of action of the arylimidamide DB766: azole interactions and role of CYP5122A1.
    Pandharkar T; Zhu X; Mathur R; Jiang J; Schmittgen TD; Shaha C; Werbovetz KA
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4682-9. PubMed ID: 24890590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting pteridine reductase 1 and dihydrofolate reductase: the old is a new trend for leishmaniasis drug discovery.
    das Neves GM; Kagami LP; Gonçalves IL; Eifler-Lima VL
    Future Med Chem; 2019 Aug; 11(16):2107-2130. PubMed ID: 31370699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid biosynthesis pathways as chemotherapeutic targets in kinetoplastid parasites.
    Urbina JA
    Parasitology; 1997; 114 Suppl():S91-9. PubMed ID: 9309771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergism in vitro of lovastatin and miconazole as anti-leishmanial agents.
    Haughan PA; Chance ML; Goad LJ
    Biochem Pharmacol; 1992 Dec; 44(11):2199-206. PubMed ID: 1472085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.